AdvancePCS offers drug discount program for all in the USA

18 March 2002

Following a string of drug-discount plan discussions in the USA,pharmacy benefit manager AdvancePCS has teamed up with 11 pharmaceutical companies to offer a discount program, the AdvancePCS RxSavings Plan. It will initially discount 21 commonly-prescribed medications, including Pfizer's hypertension treatment Accupril (quinapril), Novo Nordisk Pharmaceutical's Novolin (insulin) for diabetes and Monarch Pharmaceuticals' hypertension drug Altace (ramipril).

The Advance PCS RxSavings program is free to join and has no age or income restrictions, as do some other proposed programs. "The people who end up paying the highest price for their medications often are the ones who can least afford it," commented David Halbert, chief executive of AdvancePCS.

Furthermore, the card has a built-in safety feature to protect its holders against harmful drug interactions. An online alert is sent to the pharmacist whenever one drug may conflict with another drug the patient is taking. This is to prevent mishap to patients who may be taking several drugs that have been prescribed by different doctors.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight